Larvol Delta - Development-of-BLX3030-a-potent-and-selective-inhibitor-of-CDK9-for-the-treatment-of-NMYCdriven-NEPCS

BLX-3030 - Biolexis Therap

https://meetings.asco.org/abstracts-presentations/223403

Kyle Medley; Zhaoliang Li; Chenyu Lin; David J Bearss; Hariprasad Vankayalapati

Apr 27, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next